Tag: Drug development
From Research to Revolution: Novo Nordisk Shares Oral GLP-1 Breakthrough Story
Novo Nordisk has shared the scientific journey behind turning an injectable biologic medicine into a pill — a challenge researchers have wrestled with since...
Zydus Collaborates with ICMR to Address Sickle Cell Disease as Desidustat Enters Phase III
Zydus Lifesciences Limited, in collaboration with the Indian Council of Medical Research (ICMR), has announced the successful completion of Phase II Proof-of-Concept trials and approval...
Momentis Surgical’s Anovo Robotic System Gets FDA Approval for Multiport Surgery
Momentis Surgical has secured 510(k) clearance from the U.S. Food and Drug Administration for a multiport version of its Anovo Surgical System, the company announced July 23...
Eli Lilly Acquires AtaiBeckley to Accelerate Innovative Depression Treatments
Eli Lilly and Company and AtaiBeckley Inc. announced a agreement for Lilly to acquire AtaiBeckley. The transaction features cash consideration of $6.75 per share,...
Syngene International Inaugurates Advanced Clinical Translational Sciences Laboratory in Bengaluru
Syngene International Limited has inaugurated its state-of-the-art Clinical Translational Sciences Laboratory in Bengaluru. The milestone event was celebrated by Executive Chairperson Dr. Kiran Mazumdar Shaw,...
Novartis strikes a $1.9B partnership with Antares Therapeutics to tackle “undruggable” cancer targets.
Novartis has entered into a strategic collaboration and license agreement with Antares Therapeutics to discover and develop next-generation small molecule oncology treatments. The transaction...